Clinical Trial Update: Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mycophenolate mofetil in combination with cyclosporine for relapsing aplastic anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED